Delivery Order SPE2D021DA002-SPE2D324F6994
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,968.40 contract is for the delivery of 4,566,322,435 units of ENGERIX-B 20 MCG/ML SYRN, a specialized pharmaceutical product, with a period of performance through November 5, 2024. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract (IDC) with the DLA under...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,115.64 firm-fixed-price contract is for the supply of the pharmaceutical product "ENGERIX-B 20 MCG/ML SYRNML" with a completion date of June 18, 2024. The award is under a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Engerix-B 20 MCG/ML syringes, with a total ceiling value of $37,559.88 and a performance period through June 14, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA's Medical Supply Chain...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a ceiling value of $1,969.50 and a period of performance through May 27, 2025. DMS Pharmaceutical Group has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,395.24 contract is for the delivery of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a specialized pharmaceutical product, with a completion date of April 10, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of the pharmaceutical product ENGERIX-B 20 MCG/ML SYRN. The potential value of this order is $1,119.33. This delivery order is issued against a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with the DLA to provide a variety of pharmaceutical and medical supplies to...
- This is a $1,969.50 firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the provision of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to the Defense Logistics Agency (DLA), the funding agency. The contract has an ultimate completion date of May 30, 2025 and was awarded on May 27, 2025. DMS Pharmaceutical Group Inc. is an experienced federal contractor, holding a significant...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of ENGERIX-B 20 MCG/ML SYRN, a pharmaceutical product, with a potential value of $3,120.64 and a completion date of December 12, 2023. This delivery order is issued against a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with the Defense Logistics Agency, with a potential...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The $4,477.32 order is for the delivery of ENGERIX-B 20 MCG/ML SYRN, a pharmaceutical product. This delivery order is likely part of a larger indefinite delivery contract held by DMS Pharmaceutical Group with DLA to provide a variety of pharmaceutical and medical supplies to support military treatment facilities worldwide....
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The $3,731.10 order is for the pharmaceutical product ENGERIX-B 20 MCG/ML SYRN. The delivery order was awarded on January 31, 2022, with a completion date of February 1, 2022. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds multiple contracts and indefinite delivery vehicles (IDVs) with the...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D324F6994Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRN, a pharmaceutical product, with a ceiling value of $1,968.40 and a performance period through March 14, 2024. The contract is a firm fixed-price delivery order, which means DLA can issue orders against this contract for a variety of pharmaceutical items to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger indefinite delivery contract with DLA, valued up to $4,999,999 through 2025, that enables the agency to procure a broad range of pharmaceutical products, including flumazenil injection, prednisone tablets, and contraceptive products. This delivery order does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 3/13/24 |